Connor, Clark & Lunn Investment Management »

Silverback Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Silverback Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 290.9M1M1.1M77k78k79k80k
Value ($)Share countHistorical SPRY position of Connor, Clark & … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $851k 81k 10.55
2024-09-30 $1.1M 77k 14.50

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Shopify Cl A (SHOP)
Cibc Cad (CM)
Toronto Dominion Bk Ont Com New (TD)
Enbridge (ENB)
Agnico (AEM)
Bk Nova Cad (BNS)
Canadian Natural Resources (CNQ)
Thomson Reuters Corp. (TRI)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Suncor Energy (SU)
Canadian Natl Ry (CNI)
Manulife Finl Corp (MFC)
Waste Connections (WCN)
Tc Energy Corp (TRP)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics